Fredrik Tiberg
34Patents
8h-index
15Co-inventors
72Inventor score
Filing activity: Aug 4, 2004 → Oct 28, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8541400B2 | Compositions forming non-lamellar dispersions | Human Necessities | 61 | Active |
| US8236755B2 | Opioid depot formulations | Human Necessities | 35 | Active |
| US8097239B2 | Controlled-release formulations | Human Necessities | 35 | Active |
| US8236292B2 | Liquid depot formulations | Human Necessities | 27 | Active |
| US8546326B2 | Glp-1 analogue formulations | Human Necessities | 20 | Active |
| US8187629B2 | Non-lamellar compositions of DOPE and P80 | Human Necessities | 12 | Expired |
| US8545832B2 | Lipid depot formulations | Human Necessities | 10 | Active |
| US9585959B2 | Robust controlled-release formulations | Human Necessities | 9 | Active |
| US8920782B2 | Topical bioadhesive formulations | Human Necessities | 6 | Active |
| US9526788B2 | Pharmaceutical lipid compositions | Human Necessities | 6 | Active |
| US9649382B2 | Topical bioadhesive formulations | Human Necessities | 5 | Active |
| US9937164B2 | Opioid formulations | Human Necessities | 5 | Active |
| US9968680B2 | Topical bioadhesive formulations | Human Necessities | 5 | Active |
| US10912772B2 | Opioid formulations | Human Necessities | 4 | Active |
| US11110084B2 | Opioid formulations | Human Necessities | 2 | Active |
| US9974861B2 | Peptide slow-release formulations | Human Necessities | 2 | Active |
| US11135215B2 | Opioid formulations | Human Necessities | 2 | Active |
| US9555118B2 | Robust controlled-release peptide formulations | Human Necessities | 2 | Active |
| US9067190B2 | Method for loading amphiphile particles with active agents | Performing Operations; Transporting | 1 | Active |
| US9820934B2 | Acid containing lipid formulations | Human Necessities | 1 | Active |
| US9668967B2 | Lipid formulations comprising a thiolated antioxidant | Human Necessities | 1 | Active |
| US12029813B2 | Injectable buprenorphine formulation | Human Necessities | 1 | Active |
| US8865021B2 | Compositions of lipids and cationic peptides | Emerging Cross-Sectional Technologies | 1 | Active |
| US12161640B2 | Opioid formulations | Human Necessities | 1 | Active |
| US9522377B2 | Method for improving the properties of amphiphile particles | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.